View in EDS HTML Full Text PDF Full Text

Patients' perspectives on oral decitabine/cedazuridine for the treatment of myelodysplastic syndromes/neoplasms.

Saved in:
Bibliographic Details
Title: Patients' perspectives on oral decitabine/cedazuridine for the treatment of myelodysplastic syndromes/neoplasms.
Authors: Zeidan AM; Yale University and Yale Cancer Center, 333 Cedar Street, PO Box 208028, New Haven, CT 06520-8028, USA., Perepezko K; CorEvitas, LLC, Waltham, MA, USA., Salimi T; Taiho Oncology, Inc., Princeton, NJ, USA., Washington T; Taiho Oncology, Inc., Princeton, NJ, USA., Epstein RS; Epstein Health, LLC, Woodcliff Lake, NJ, USA.
Source: Therapeutic advances in hematology [Ther Adv Hematol] 2024 Jul 30; Vol. 15, pp. 20406207241257313. Date of Electronic Publication: 2024 Jul 30 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101549589 Publication Model: eCollection Cited Medium: Print ISSN: 2040-6207 (Print) Linking ISSN: 20406207 NLM ISO Abbreviation: Ther Adv Hematol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39091323
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Patients' perspectives on oral decitabine/cedazuridine for the treatment of myelodysplastic syndromes/neoplasms.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zeidan+AM%22">Zeidan AM</searchLink>; Yale University and Yale Cancer Center, 333 Cedar Street, PO Box 208028, New Haven, CT 06520-8028, USA.<br /><searchLink fieldCode="AU" term="%22Perepezko+K%22">Perepezko K</searchLink>; CorEvitas, LLC, Waltham, MA, USA.<br /><searchLink fieldCode="AU" term="%22Salimi+T%22">Salimi T</searchLink>; Taiho Oncology, Inc., Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Washington+T%22">Washington T</searchLink>; Taiho Oncology, Inc., Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Epstein+RS%22">Epstein RS</searchLink>; Epstein Health, LLC, Woodcliff Lake, NJ, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101549589%22">Therapeutic advances in hematology</searchLink> [Ther Adv Hematol] 2024 Jul 30; Vol. 15, pp. 20406207241257313. <i>Date of Electronic Publication: </i>2024 Jul 30 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101549589 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2040-6207 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220406207%22">20406207 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Hematol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39091323
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/20406207241257313
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 20406207241257313
    Titles:
      – TitleFull: Patients' perspectives on oral decitabine/cedazuridine for the treatment of myelodysplastic syndromes/neoplasms.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zeidan AM
      – PersonEntity:
          Name:
            NameFull: Perepezko K
      – PersonEntity:
          Name:
            NameFull: Salimi T
      – PersonEntity:
          Name:
            NameFull: Washington T
      – PersonEntity:
          Name:
            NameFull: Epstein RS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 07
              Text: 2024 Jul 30
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2040-6207
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Therapeutic advances in hematology
              Type: main
ResultId 1